Amylyx Pharmaceuticals announced that its current cash reserves are expected to be sufficient to support the company's operations, not only covering the potential commercialization process of the new drug Avexitide, but also sustaining operations through 2028.

Amylyx Pharmaceuticals announced that its current cash reserves are expected to be sufficient to support the company's operations, not only covering the potential commercialization process of the new drug Avexitide, but also sustaining operations through 2028.

老虎证券2026/03/03 12:33

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This funding plan provides a stable financial foundation for the company's medium and long-term development.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Amylyx Pharmaceuticals announced that its current cash reserves are expected to be sufficient to support the company's operations, not only covering the potential commercialization process of the new drug Avexitide, but also sustaining operations through 2028.

You may also like

Crypto prices